Log in
Enquire now
‌

US Patent 11780816 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase

Patent 11780816 was granted and assigned to Translational Drug Development (Td2) on October, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Translational Drug Development (Td2)
Translational Drug Development (Td2)
Current Assignee
Translational Drug Development (Td2)
Translational Drug Development (Td2)
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11780816
Patent Inventor Names
Tong Wang
Stephen Gately
Date of Patent
October 10, 2023
Patent Application Number
17588945
Date Filed
January 31, 2022
Patent Primary Examiner
‌
Shawquia Jackson
CPC Code
‌
C07D 405/06
‌
C07D 235/30
Patent abstract

The present invention is directed to novel aminobenzimidazole derivatives. The present invention is also directed to methods of treating a histone deacetylase (HDAC)-associated disease or inhibiting the histone deacetylating activity of a HDAC isoform in a cell or with one or more of the aminobenzimidazole derivatives.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11780816 Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us